I would have thought the current ones would have already been accounted for and paid for. (I'm only guessing that IMAX would want the money upfront)
in regards to further clinical trials I have no doubt we'll be doing phase 3 with burns and phase 2 with IV sepsis. I just think the time lines for those won't be in the next 12month. I think by the time regulating bodies look over the peer checked data and things get organised for the go ahead it'll be 12m+
it's only my opinion based on the last trials. we were talking about burns and IV in 2019. we're 2022 now.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.025(5.62%) |
Mkt cap ! $121.4M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.0¢ | 41.5¢ | $45.92K | 107.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 120 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 1000 | 1 |
View Market Depth
| Last trade - 15.59pm 28/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |